Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labia

Showing results (101-110 of 185) with videos related to

Pageof 19
Sort By:
Pathologie-Biologie|June 1, 1986
[Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins]R Labia, A Morand, M Guionie, et al.
Annales De Microbiologie|January 1, 1983
[Affinity of N-formimidoyl-thienamycin (MK-0787) for beta-lactamases, analysis by a statistical method: correspondence analysis]R Labia, M Guionie, A Morand, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coliP Nordmann, S Mariotte, T Naas, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu strictoL Poirel, F Laurent, T Naas, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Characterization of an inhibitor-resistant TEM (IRT) beta-lactamase in a novel strain of Klebsiella pneumoniaeH Bermudes, F Jude, C Arpin, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9C Aumeran, C Chanal, R Labia, et al.
Pathologie-Biologie|June 1, 1987
[Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams]R Labia, A Morand, J S Pitton, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidimeR Labia, A Thabaut, A Morand, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1992
A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymesH Bernard, C Tancrede, V Livrelli, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 22, 2005
Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiinesF Zentz, R Labia, D Sirot, et al.
Pageof 19

Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
Pathologie-Biologie|June 1, 1986
[Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins]R Labia, A Morand, M Guionie, et al.
Annales De Microbiologie|January 1, 1983
[Affinity of N-formimidoyl-thienamycin (MK-0787) for beta-lactamases, analysis by a statistical method: correspondence analysis]R Labia, M Guionie, A Morand, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coliP Nordmann, S Mariotte, T Naas, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu strictoL Poirel, F Laurent, T Naas, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Characterization of an inhibitor-resistant TEM (IRT) beta-lactamase in a novel strain of Klebsiella pneumoniaeH Bermudes, F Jude, C Arpin, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9C Aumeran, C Chanal, R Labia, et al.
Pathologie-Biologie|June 1, 1987
[Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams]R Labia, A Morand, J S Pitton, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidimeR Labia, A Thabaut, A Morand, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1992
A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymesH Bernard, C Tancrede, V Livrelli, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 22, 2005
Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiinesF Zentz, R Labia, D Sirot, et al.
Pageof 19